ANTI-SYNDECAN-4 ANTIBODIES
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 5, 2013
app pub date -
Aug 11, 2011
filing date -
Aug 12, 2010
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention relates to a recognition molecule against Syndecan-4, wherein said recognition molecule binds an epitope contained in an amino acid sequence corresponding to the amino acid sequence between amino acids 93 and 121 of the amino acid sequence shown in SEQ ID NO: 1 (FIG. 1) for use in the treatment and/or prevention of a pathological medical condition associated with turnover of the extracellular matrix and/or cartilage remodelling in which Syndecan-4 is involved. Said pathological condition is preferably osteoarthritis or rheumatoid arthritis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully